Benitec resumes manufacturing of HIV/AIDS therapeutic

By Lisa Kerner

Charlotte, N.C., June 22 - Benitec Ltd. said it has resolved issues related to manufacturing its clinical materials for HIV/AIDS therapeutics. As a result, GMP manufacturing has resumed.

The company said the issues were not safety-related, but test-result related.

Benitec is an Australian biotechnology company using its proprietary RNAi technology to develop treatments for HIV and hepatitis C virus.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.